NZ High Court rejects cannabis maker's injunction against rival's product guide

Court ruling denies preliminary relief in competitive dispute over marketing materials in New Zealand's medical cannabis sector.

FILE — dealmaking · Perzon SEO / CC BY 2.0

New Zealand's High Court has declined to grant an injunction sought by a cannabis manufacturer against a competitor over a product guide, according to Australasian Lawyer. The refusal suggests the court found insufficient grounds for urgent interim relief—typically a high bar requiring demonstration of serious harm and balance of convenience in the applicant's favor.

The ruling occurs as New Zealand's medical cannabis landscape undergoes consolidation. Recent months have seen major structural moves, including Ora Pharm's acquisition of Helius for export capability and leadership changes at firms like Fluent. A March 2026 report noted market growth slowdown with at least one major operator entering administration, indicating rising competitive pressures.

Watch whether this judgment prompts similar competitive challenges in the sector or signals courts' reluctance to intervene in marketing disputes absent clear infringement of intellectual property or regulatory breaches. The outcome may affect how New Zealand cannabis firms navigate product positioning as the market matures.